These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1693315)

  • 1. The potential for adjuvant therapy in early-stage cervical cancer.
    Buxton EJ; Saunders N; Blackledge GR; Kelly K; Redman CW; Monaghan J; Paterson ME; Luesley DM
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S17-21. PubMed ID: 1693315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
    Buxton EJ
    Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix.
    Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ
    Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of ifosfamide in cervical cancer.
    Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer.
    Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N
    Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer.
    Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
    Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
    [No Abstract]   [Full Text] [Related]  

  • 10. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
    Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of postoperative simple chemotherapy and concurrent chemoradiotherapy in FIGO stage IB2-IIB cervical cancer].
    Ma K; Yang YH; Yang X; Feng ZY; Liu TY; Wen HW; Liao QP
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):910-5. PubMed ID: 24343073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant and adjuvant chemotherapy of cervical cancer: mature results of the phase 2 PBM-PFU protocol.
    McCaffrey R; Bahtiyar M; Kohorn EI; Chambers JT; Schwartz PE; Chambers SK
    Int J Gynecol Cancer; 2011 Apr; 21(3):535-44. PubMed ID: 21436702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy.
    Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS
    Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy for locally advanced cervical cancer reduces surgical risks and lymph-vascular space involvement.
    Wang Y; Wang G; Wei LH; Huang LH; Wang JL; Wang SJ; Li XP; Shen DH; Bao DM; Gao J
    Chin J Cancer; 2011 Sep; 30(9):645-54. PubMed ID: 21880186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
    Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
    Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II studies of ifosfamide alone and in combination in cancer of the cervix.
    Blackledge G; Buxton EJ; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
    Cancer Chemother Pharmacol; 1990; 26 Suppl():S12-6. PubMed ID: 1693314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined chemotherapy using cisplatin, ifosfamide and bleomycin (PIB) in the treatment of advanced and recurrent cervical carcinoma.
    Tay SK; Lai FM; Soh LT; Ho TH; Ang PT; Au E
    Aust N Z J Obstet Gynaecol; 1992 Aug; 32(3):263-6. PubMed ID: 1280100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.